Expression of XPO4, MAP2K4 and ZIC1 in endometrial cancer tissues and prognostic value in endometrial cancer patient

doi:10.3877/cma.j.issn.1673-5250.2021.04.005

Objective

To explore expression of exportin (XPO)4, mitogen-activated protein kinase (MAP2K)4 and zinc finger protein of cerebellum (ZIC)1 in endometrial cancer (EC) tissues and their prognostic values in EC patient.

Methods

From June 2017 to June 2018, a total of 147 EC patients admitted to Wuxi Maternal and Child Health Hospital and Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University were selected as research subjects. Expression levels of XPO4, MAP2K4 and ZIC1 in EC tissues and adjacent normal tissues of EC patients were detected by immunohistochemical staining method. Positive rates of XPO4, MAP2K4, and ZIC1 in EC tissues and adjacent normal tissues of EC patients, as well as positive rates of XPO4, MAP2K4, and ZIC1 in EC tissues of EC patients with different clinicopathological characteristics were compared by chi-square test. Two-stage test was used to compare 3-year overall survival (OS) rates of EC patients with XPO4, MAP2K4, ZIC1 positive expression and negative expression in EC tissues. This study was approved by the Ethics Committee of Wuxi Maternal and Child Health Hospital and Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University (approval No. 20160803, 20160502).

Results

①The positive rates of XPO4 and MAP2K4 in EC tissues of EC patients were 34.7% (51/147) and 38.1% (56/147) respectively, which were statistically lower than those in adjacent normal tissues 66.7% (98/147) and 72.8% (107/147), and both differences were statistically significant (χ²=30.060, 35.812; P<0.001). The positive rate of ZIC1 in EC tissues of EC patients was 72.1% (106/147), which was statistically higher than that in adjacent normal tissues 40.1% (59/147), and the difference was statistically significant (χ²=30.512, P<0.001). ②The positive rates of XPO4, MAP2K4, and ZIC1 in EC tissues of EC patients with different age, EC diameter and menopausal or not were compared, and the differences were not statistically significant (P>0.05). While there were statistically significant differences in the positive rates of XPO4, MAP2K4 and ZIC1 in EC tissues of EC patients with different International Federation of Obstetrics and Gynecology (FIGO) stages, histopathological grades, myometrial invasion degree, and lymph node metastasis (P<0.05). ③The 3-year OS rates of EC patients with negative expression of XPO4 and MAP2K4 were 42.7% and 38.5% respectively, which were statistically lower than those of patients with positive expression of XPO4 and MAP2K4 68.6% and 71.4%, and both differences were statistically significant (χ²=8.960, P=0.003; χ²=15.077, P<0.001). The 3-year OS rate of EC patients with positive expression of ZIC1 was 35.8%, which was statistically lower than that of patients with ZIC1 negative expression, and the difference was statistically significant (χ²=12.579, P<0.001).

Conclusions

XPO4 and MAP2K4 are lowly expressed, and ZIC1 is highly expressed in EC tissues. Expression levels of XPO4, MAP2K4 and ZIC1 are related to the histopathological grade, lymph node metastasis, FIGO stage, myometrial invasion, and 3-year OS rate of EC patients, and they have certain values in assessing the development, progression and prognosis of EC patients.

Key words: Endometrial neoplasms, Exportin-4, Mitogen-activated protein kinase 4, Zinc finger protein of cerebellum 1, Prognosis, Female

表1 本组EC患者EC组织及癌旁正常组织的XPO4、MAP2K4、ZIC1阳性率比较[例数(%)]

组别	例数	XPO4	MAP2K4	ZIC1
EC组织	147	51(34.7)	56(38.1)	106(72.1)
癌旁正常组织	147	98(66.7)	107(72.8)	59(40.1)
χ²值		30.060	35.812	30.512
P值		<0.001	<0.001	<0.001

表1 本组EC患者EC组织及癌旁正常组织的XPO4、MAP2K4、ZIC1阳性率比较[例数(%)]

组别	例数	XPO4	MAP2K4	ZIC1
EC组织	147	51(34.7)	56(38.1)	106(72.1)
癌旁正常组织	147	98(66.7)	107(72.8)	59(40.1)
χ²值		30.060	35.812	30.512
P值		<0.001	<0.001	<0.001

图1 本组1例EC患者(38岁，FIGO分期为Ⅱ期，伴淋巴结转移)EC组织及癌旁正常组织XPO4、MAP2K4、ZIC1免疫组化检测结果(图1A：EC组织XPO4检测结果；图1B：癌旁正常组织XPO4检测结果；图1C：EC组织MAP2K4检测结果；图1D：癌旁正常组织MAP2K4检测结果；图1E：EC组织ZIC1检测结果；图1F：癌旁正常组织ZIC1检测结果)(免疫组化染色，高倍)

表2 本组EC患者的EC组织XPO4、MAP2K4、ZIC1阳性率比较[例数(%)]

类别			例数	XPO4			MAP2K4			ZIC1
类别			例数	阳性	χ²值	P值	阳性	χ²值	P值	阳性	χ²值	P值
年龄(岁)					0.027	0.869		0.098	0.754		0.529	0.467
		<50	27	9(33.3)			11(40.7)			21(77.8)
		≥50	120	42(35.0)			45(37.5)			85(70.8)
EC直径(cm)					0.061	0.804		0.013	0.910		0.037	0.847
		<4.0	77	26(33.8)			29(37.7)			55(71.4)
		≥4.0	70	25(35.7)			27(38.6)			51(72.9)
绝经					0.005	0.942		0.034	0.853		0.028	0.866
	否		38	13(34.2)			14(36.8)			27(71.1)
	是		109	38(34.9)			42(38.5)			79(72.5)
FIGO分期(期)					6.565	0.010		6.491	0.011		9.525	0.002
	Ⅰ~Ⅱ		115	46(40.0)			50(43.5)			76(66.1)
	Ⅲ		32	5(15.6)			6(18.8)			30(93.8)
组织病理学分级(级)					3.963	0.047		5.236	0.022		6.032	0.014
	G1~G2		127	48(37.8)			53(41.7)			87(68.5)
	G3		20	3(15.0)			3(15.0)			19(95.0)
子宫肌层侵犯(%)					8.434	0.004		9.046	0.003		15.640	<0.001
	<50		105	44(41.9)			48(45.7)			66(62.9)
	≥50		42	7(16.7)			8(19.0)			40(95.2)
淋巴结转移					9.407	0.002		9.884	0.002		8.746	0.003
	否		107	45(42.1)			49(45.8)			70(65.4)
	是		40	6(15.0)			7(17.5)			36(90.0)

表2 本组EC患者的EC组织XPO4、MAP2K4、ZIC1阳性率比较[例数(%)]

类别			例数	XPO4			MAP2K4			ZIC1
类别			例数	阳性	χ²值	P值	阳性	χ²值	P值	阳性	χ²值	P值
年龄(岁)					0.027	0.869		0.098	0.754		0.529	0.467
		<50	27	9(33.3)			11(40.7)			21(77.8)
		≥50	120	42(35.0)			45(37.5)			85(70.8)
EC直径(cm)					0.061	0.804		0.013	0.910		0.037	0.847
		<4.0	77	26(33.8)			29(37.7)			55(71.4)
		≥4.0	70	25(35.7)			27(38.6)			51(72.9)
绝经					0.005	0.942		0.034	0.853		0.028	0.866
	否		38	13(34.2)			14(36.8)			27(71.1)
	是		109	38(34.9)			42(38.5)			79(72.5)
FIGO分期(期)					6.565	0.010		6.491	0.011		9.525	0.002
	Ⅰ~Ⅱ		115	46(40.0)			50(43.5)			76(66.1)
	Ⅲ		32	5(15.6)			6(18.8)			30(93.8)
组织病理学分级(级)					3.963	0.047		5.236	0.022		6.032	0.014
	G1~G2		127	48(37.8)			53(41.7)			87(68.5)
	G3		20	3(15.0)			3(15.0)			19(95.0)
子宫肌层侵犯(%)					8.434	0.004		9.046	0.003		15.640	<0.001
	<50		105	44(41.9)			48(45.7)			66(62.9)
	≥50		42	7(16.7)			8(19.0)			40(95.2)
淋巴结转移					9.407	0.002		9.884	0.002		8.746	0.003
	否		107	45(42.1)			49(45.8)			70(65.4)
	是		40	6(15.0)			7(17.5)			36(90.0)

图2 本组EC组织XPO4、MAP2K4、ZIC1呈阳性与呈阴性EC患者的OS曲线分析(图2A：XPO4呈阳性与呈阴性EC患者OS曲线；图2B：MAP2K4呈阳性与呈阴性EC患者OS曲线；图2C：ZIC1呈阳性与呈阴性EC患者OS曲线)

[1]	赵玲，尹香花. LKB1-AMPK-mTOR信号通路在子宫内膜癌的研究现状[J/CD]. 中华妇幼临床医学杂志(电子版), 2019, 15(2): 228-232. DOI: 10.3877/cma.j.issn.1673-5250.2019.02.017.
[2]	王秀琪，孙智晶，郎景和. 子宫内膜癌的筛查[J]. 中国实用妇科与产科杂志，2019, 12(11): 231-234. DOI: 10.19538/j.fk2019110122.
[3]	赵文荣，程静新. 老年子宫内膜癌的诊疗策略[J]. 实用妇产科杂志，2019, 35(8): 567-570.
[4]	Aksu M, Trakhanov S, Görlich D. Structure of the exportin Xpo4 in complex with RanGTP and the hypusine-containing translation factor eIF5A[J]. Nat Commun, 2016, 7(1): 11952. DOI: 10.1038/ncomms11952.
[5]	Xue Z, Vis DJ, Bruna A, et al. MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models[J]. Cell Res, 2018, 28(7): 719-729. DOI: 10.1038/s41422-018-0044-4.
[6]	Perugini J, Bordoni L, Venema W, et al. Zic1 mRNA is transiently upregulated in subcutaneous fat of acutely cold-exposed mice[J]. J Cell Physiol, 2019, 234(3): 2031-2036. DOI: 10.1002/jcp.27301.
[7]	刘蜀，刘祎祎，李荣. 丝裂原活化蛋白激酶激酶4和雌激素受体的表达在浸润性乳腺癌组织中的临床意义[J]. 南方医科大学学报，2017, 37(4): 488-493. DOI: 10.3969/j.issn.1673-4254.2017.04.11.
[8]	吴楠，黄静，陈阳，等. 重组诱导性质粒Egr1-XPO4的构建及其与5-FU联合对肝癌细胞SK-Hep1的协同抑制作用[J]. 中国肿瘤生物治疗杂志，2018, 25(2): 132-136. DOI: 10.3872/j.issn.1007-385x.2018.02.004.
[9]	王杰锋，肖金坛，盛臻芳，等. ZIC1过表达对结直肠癌HCT-116细胞增殖及对苦参碱类生物碱药物敏感性的影响[J]. 现代肿瘤医学，2019, 27(3): 386-389. DOI: 10.3969/j.issn.1672-4992.2019.03.006.
[10]	林仲秋. 《FIGO 2015妇癌报告》解读连载二——子宫内膜癌诊治指南解读[J]. 中国实用妇科与产科杂志，2015, 31(11): 986-991. DOI: 10.7504/fk2015100120.
[11]	李雪丹，佟晓光，刘屹，等. 磁共振成像在子宫内膜癌术前分期及肌层浸润深度判定中的作用(依照新修订的FIGO分期系统)[J]. 现代肿瘤医学，2011, 2(12): 2511-2514. DOI: 10.3969/j.issn.1672-4992.2011.12.51.
[12]	曹作增，滕银成. 子宫内膜癌组织HER2表达水平与患者临床病理特征的关系探讨[J]. 癌症进展，2017, 15(11): 1312-1314. DOI: 10.11877/j.issn.1672-1535.2017.15.11.22.
[13]	Fitzgibbons PL, Bradley LA, Fatheree LA, et al. Principles of analytic validation of immunohistochemical assays: Guideline from the College of American Pathologists Pathology and Laboratory Quality Center[J]. Arch Pathol Lab Med, 2014, 138(11): 1432-1443. DOI: 10.5858/arpa.2013-0610-CP.
[14]	陈红燕，李莉莉，罗钦，等. 子宫内膜癌患者血清和癌组织中CDCA5表达变化及其诊断价值分析[J]. 山东医药，2019, 59(2): 58-60. DOI: 10.3969/j.issn.1002-266X.2019.02.016.
[15]	刘婷婷，高维萍，刘琼娜，等. MIMECAN基因、细胞核因子κB和白细胞介素24与子宫内膜癌的相关性研究[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(2): 232-235. DOI: 10.3877/cma.j.issn.1673-5250.2015.02.018.
[16]	刘婷婷，张淑香，高维萍. 血清瘦素和胰岛素生长因子Ⅱ与子宫内膜癌的相关性研究 [J/CD]. 中华妇幼临床医学杂志(电子版), 2013, 9(5): 650-652. DOI: 10.3877/cma.j.issn.1673-5250.2013.05.018.
[17]	Song N, Zhang Y, Kong F, et al. HOXA-AS2 promotes type Ⅰ endometrial carcinoma via miRNA-302c-3p-mediated regulation of ZFX[J]. Cancer Cell Int, 2020, 20: 359. DOI: 10.1186/s12935-020-01443-0.
[18]	唐上坤，张效杰，肖华，等. MRI与血清肿瘤标志物联合诊断子宫内膜癌的临床价值[J]. 中国CT和MRI杂志，2018, 16(3): 83-84,封2. DOI: 10.3969/j.issn.1672-5131.2018.03.026.
[19]	李冉红，岳驰，刘辉. 肿瘤标志物在子宫内膜癌诊断和预后评估中的研究进展[J/CD]. 中华妇幼临床医学杂志(电子版), 2016, 12(4): 484-488. DOI: 10.3877/cma.j.issn.1673-5250.2016.04.022.
[20]	郝琦蓉，任艺婷，胡晶晶，等. 基于TCGA数据库的子宫内膜癌差异基因患者的预后预测模型构建[J/CD]. 中华妇幼临床医学杂志(电子版), 2021, 17(2): 181-189. DOI: 10.3877/cma.j.issn.1673-5250.2021.02.009.
[21]	Xu F, Jia M, Li X, et al. Exportin-4 coordinates nuclear shuttling of TOPLESS family transcription corepressors to regulate plant immunity[J]. Plant Cell, 2021, 33(3): 697-713. DOI: 10.1093/plcell/koaa047.
[22]	Zain SM, Mohamed Z, Pirmohamed M, et al. Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non-alcoholic fatty liver disease[J]. Sci Rep, 2015, 5: 13306. DOI: 10.1038/srep13306.
[23]	Zain SM, Mohamed Z, Pirmohamed M, et al. Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non-alcoholic fatty liver disease[J]. Sci Rep, 2015, 5: 13306. DOI: 10.1038/srep13306.
[24]	Xu F, Jia M, Li X, et al. Exportin-4 coordinates nuclear shuttling of TOPLESS family transcription corepressors to regulate plant immunity[J]. Plant Cell, 2021, 33(3): 697-713. DOI: 10.1093/plcell/koaa047.
[25]	Liang XT, Pan K, Chen MS, et al. Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2011, 26(3): 544-549. DOI: 10.1111/j.1440-1746.2010.06434.x.
[26]	Zhang F, Fan YC, Mu NN, et al. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection[J]. J Viral Hepat, 2014, 21(4): 241-250. DOI: 10.1111/jvh.12136.
[27]	Chen L, Huang Y, Zhou L, et al. Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma[J]. Biosci Rep, 2019, 39(8): BSR20190827. DOI: 10.1042/BSR20190827.
[28]	Mundt F, Rajput S, Li S, et al. Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple negative breast cancers[J]. Cancer Res, 2018, 78(10): 2732-2746. DOI: 10.1158/0008-5472.CAN-17-1990.
[29]	Xue Z, Vis DJ, Bruna A, et al. MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models[J]. Cell Res, 2018, 28(7): 719-729. DOI: 10.1038/s41422-018-0044-4.
[30]	Niu J, Li Z, Li F. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4[J]. Am J Physiol Gastrointest Liver Physiol, 2019, 317(5): G670-G681. DOI: 10.1152/ajpgi.00055.2019.
[31]	Dubey A, Yu J, Liu T, et al. Retinoic acid production, regulation, and containment through Zic1, Pitx2c and Cyp26c1 control cranial placode specification[J]. Development, 2021, 148(4): dev193227. DOI: 10.1242/dev.193227.
[32]	Han W, Zhang C, Gao XJ, et al. Clinicopathologic and prognostic significance of the zinc finger of the cerebellum family in invasive breast cancer[J]. J Breast Cancer, 2018, 21(1): 51-61. DOI: 10.4048/jbc.2018.21.1.51.
[33]	Perugini J, Bordoni L, Venema W, et al. Zic1 mRNA is transiently upregulated in subcutaneous fat of acutely cold-exposed mice[J]. J Cell Physiol, 2019, 234(3): 2031-2036. DOI: 10.1002/jcp.27301.
[34]	Aruga J, Millen KJ. ZIC1 function in normal cerebellar development and human developmental pathology[J]. Adv Exp Med Biol, 2018, 1046: 249-268. DOI: 10.1007/978-981-10-7311-3_13.
[35]	Gu X, Guo XK, Chen BH, et al. Prognostic and clinicopathological value of ZIC1 in patients with cervical squamous cell carcinoma[J]. Oncol Lett, 2019, 18(6): 6621-6627. DOI: 10.3892/ol.2019.11007.
[36]	Han W, Cao F, Gao XJ, et al. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin[J]. Int J Oncol, 2018, 53(4): 937-948. DOI: 10.3892/ijo.2018.4450.

[1]	Kang Ying, Canying Yang, Fengzhen Liu, Lili Chen, Yanna Liu. Prognostic value of left ventricular myocardial strain in asymptomatic patients with severe aortic stenosis[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(06): 581-587.
[2]	Xiaoli Yi, Shasha Hu, Yan Zhang. Impact of HER-2 low expression on response of neoadjuvant chemotherapy and prognosis in breast cancer patients[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 340-346.
[3]	Jie Shi, Yuntao Li, Haiyan Gao. Prognosis of node-positive luminal A breast cancer patients with neoadjuvant and adjuvant chemotherapy and influencing factors[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 353-361.
[4]	Siping Zhang, Wei Liu, Pengcheng Ma. Therapeutic effects of lower extremity mild varus alignment after total knee arthroplasty[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(06): 808-817.
[5]	Yuezhou Li, Kongxi Zhang, Xiaohong Li, Zhonghua Shang. Prognostic significance of PUM in gastric carcinoma based on bioinformatics analysis[J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 426-432.
[6]	Jun Zhang, Zai Luo, Mingyu Duan, Zhengjun Qiu, Chen Huang. Research progress of prognostic prediction models for gastric cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 456-461.
[7]	Qian Yang, Cuifang Li, Wanqiu Zhang. Analysis of short-term and long-term prognosis and influencing factors of primary liver cancer with spontaneous ruptured hemorrhage after emergency TACE surgery[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 33-36.
[8]	Yansong Li, Huimin Feng, Mingchao Liu, Zepeng Liu, Qiuxia Jiang. Expression and clinical significance of STIP1 in triple negative breast cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 52-56.
[9]	Zhenjian Jiang, Ming Jiang, Dali Huang. The expression and prognostic value of TK1 and Ki67 proteins in differentiated thyroid carcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 623-626.
[10]	Qingyan Yan, Xiaomei Yong, Hong Luo, Min Du. Prognostic factors and survival analysis of multicenter elderly patients with metastatic breast cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 636-638.
[11]	Xin Lu, Jiayi Xu, Yang Liu, Qin Yang, Wenwen Ju, Yinglong Xu. Comparison of the effects of early LC and PTCD continuous LC on liver function and prognosis of patients with acute cholecystitis[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 648-650.
[12]	Yanjun Lu, Jian Ma, Pengyu Bai, Linghong Guo, Haiyi Liu, Bo Jiang, Wenqi Bai, Yixun Zhang. Clinical effect of Nano-carbon on 253 groups of lymph node dissection in laparoscopic radical resection of rectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 473-477.
[13]	Yongsheng Li, Jiahe Sun, Shuwei Guo, Yikang Lu, Hongzhou Liu. Short-term postoperative complications and their influencing factors in elderly patients with colorectal cancer[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(9): 962-967.
[14]	Jun Wang, Kunpeng Liu, Lan Yao, Hua Zhang, Yue Wei, Libin Suo, Jun Chen, chengli Miao, Chenghua Luo. Retrospective analysis of anesthesia management of massive transfusion patients undergoing retroperitoneal tumor resection[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 844-849.
[15]	Libin Suo, Kunpeng Liu, Lan Yao, Hua Zhang, Yue Wei, Jun Wang, Jun Chen, Chengli Miao, Chenghua Luo. Key points of anesthesia management and prognostic factors in patients undergoing primary retroperitoneal paraganglioma resection[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 771-776.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export